Clinical Trial Update: A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating momelotinib in adults with low-risk myelodysplastic syndromes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Momelotinib (momelotinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING